Abstracts / Abstrakts
- 43) Leopold G, Belz GG, Ungethüm W, Breithaupt K,Longerich
S, Simane S, Winkler W. Non-interaction of the pharmacokinetics
of bisoprolol (BISO) and hydrochlorothiazide (HCTZ). Europ
J Clin Pharmacol 1989;36(Suppl.):A262.
- 44) Welker HA, Eggers H, Kleinbloesem C, Erb K, Breithaupt
K, Butzer R, Belz GG.Ro 40-5967: Pharmacokinetics of a
new calcium antagonist. Europ J Clin Pharmacol 1989;36(Suppl.):A304.
- 45) Schmitt R, Kleinbloesem CH, Belz GG.Ro 40-5967
a calcium antagonist of a new generation? Europ J Clin Pharmacol
1989;36(Suppl.):A336.
- 46) Breithaupt K, Schloos J, Baehr J, Belz GG, Palm D. Hemodynamic
effects of celiprolol versus metoprolol in man on the basis
of comparable ß-receptor occupancy. Naunyn-Schmiedeberg's Arch
Pharmacol 1990;341(Suppl.):R108.
- 47) Belz GG, Schroeter V, Kharkevitch T, Wolf GK.Haemodynamic
effects of a new imidazole derivative in man. Clin Pharmacol Ther
1990;47:196.
- 48) Belz GG, Erb K, Breithaupt K, Butzer R, Schmitt R,
Kleinbloesem CH.Pharmacodynamics of a calcium
antagonist of a new chemical class. Clin Pharmacol Ther 1990;47:198.
- 49) Belz GG, Breithaupt K, Erb KA, Wolf GK. Non-invasive
assessment on stroke volume in clinical pharmacology. Brit J Clin
Pharmacol 1990;640 P.
- 50) Erb KA, de Mey C, Leschinger MI, Kroll M, Wolf GK,
Belz GG.Evaluating oral nitroglycerin sprays with digital
pulse plethysmography (DPG). Naunyn-Schmiedeberg's Arch Pharmacol
1991;343(Suppl.):R 126.
- 51) Schmitt R, Belz GG, Pozenel H, Kirch W, Woittiez AJJ,
Kleinbloesem CH.Haemodynamic effects of the novel
calcium agonist Ro 40-5967 in hypertensive patients. Brit J Clin
Pharmacol 1991;31:578P-579P.
- 52) Kleinbloesem CH, Fahrner E, Weber C, Dellenbach M,
Schroeter V, Belz GG.Haemodynamics, biochemical effects
and pharmacokinetics of the renin inhibitor Ro 42-5892 in healthy
man. Brit J Clin Pharmacol 1991;31:588P-589P.
- 53) Breithaupt K, de Mey C, Schreck W, Dieterich HA, Belz
GG.Effects
of the ACE-inhibitor captopril, the PDE III-inhibitor enoximone and
their combination on aorto femoral pulse wave velocity in healthy
subjects. Pflügers Archiv Europ J Physiol 1991;419(Suppl.1):R
127.
- 54) Schloos J, Reiff K, Schulz J, Belz GG.Time
course of ß1 and Â1 adrenoceptor blocking activities
after oral administration of carvedilol to healthy volunteers. Naunyn-Schmiedeberg's
Arch Pharmacol 1992;345(Suppl.):R 83.
- 55) Belz GG, Schroeter V, de Mey C, Butzer R, Bühring
KU, Ungethüm W, Leopold G. Effect-concentration-relationships
for the PDE III-Phosphodiesterase inhibitors isomazole
and meribendan in healthy man. Clin Pharmacol Ther 1992;51:152.
- 56) Belz GG, Butzer R, Erbel R, de Mey C, Nixdorff U, Schroeter
V. Relative sensivity of various noninvasive estimates
of the effect of isoprenaline in man. Clin Pharmacol Ther
1992;51:172.
< > 1 2 3 4 5 6 7 8